Author

Anjali V. Sheahan

Harvard UniversityORCID 0000-0003-1919-1655Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Beatriz GermaniD· 1 shared Deborah L. BurkhartiD· 1 shared Hannah E. BergomiD· 1 shared Himisha BeltraniD· 1 shared Jagpreet Singh NandaiD· 1 shared Justin H. HwangiD· 1 shared Kate LawrensoniD· 1 shared Katherine L. MoreliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Beatriz GermanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedAug 8, 2024

MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer

Beatriz German, Sarah Abou Alaiwi, Kun-Lin Ho…·Leigh Ellis

This study identifies MYBL2 as a master regulator of phenotypic plasticity in prostate cancer and shows CDK2 inhibition as a potential therapeutic strategy for MYBL2-driven tumors.

19 citations

mousebulk RNA-seq

𝕏 PostBluesky